| Study | MRI technique | MRI reading | MRI‐TBx | ||||||
| Study | Inclusion period | Machine |
Magnetic field strength |
Pulse sequences |
Endorectal coil |
MRI score system | Experience / consensus reading | Technique | N cores |
| Diagnostic test accuracy analyses studies | |||||||||
| Abd‐Alazeez 2014 | < Apr 2013 | Achieva, Philips/Avanto, Siemens | 1.5 & 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / NR | Cognitive | NR |
| Ahmed 2017 | May 2012 Nov 2015 | NR | 1.5 | T2, DWI, DCE | No | PI‐RADS v1a | Experienced / NR | NA | NA |
| Dal Moro 2019 | Jan 2013 Dec 2016 | NR | 1.5 | T2, DWI | NR | PI‐RADS v1 | Experienced / NR | Cognitive | 1/lesion |
| Distler 2017 | Oct 2012 Dec 2015 | Magnetom Prisma, Siemens/Biograph mMR, Siemens | 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / No | BiopSee, Pi Medical/MedCom (rigid) | 3/lesion |
| Grey 2015 | Jul 2012 Nov 2013 | Signa Excite, GE/Magnetom Symphony, Siemens | 1.5 | T2, DWI | No | PI‐RADS v1 | Experienced / No | Cognitive | NR |
| Hansen 2016a | Mar 2013 Oct 2015 | NR | 1.5 & 3 | T2, DWI | No | PI‐RADS v1 | Experienced / No | BiopSee, Pi Medical/MedCom (rigid) | 2/lesion |
| Hansen 2018 | Oct 2012 May 2016 | Discovery MR450/MR750 HDx, GE/Magnetom, Siemens | 1.5 & 3 | T2, DWI, DCE | NR | PI‐RADS v1, v2 | Experienced / Yes | BiopSee, Pi Medical/MedCom (rigid) | 2‐4/pt (IQR 2‐5) |
| Hansen 2017 | Oct 2013 Nov 2015 | Magnetom, Siemens | 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / NR | BiopSee, Pi Medical/MedCom (rigid) | 2/pt (IQR 2‐4) |
| Kesch 2017 | Oct 2013 Mar 2014 | Magnetom, Siemens | 3 | T2, DWI, DCE | NR | PI‐RADS v1 | Experienced / NR | BiopSee, Pi Medical/MedCom (rigid) | 2/lesion (range 2‐3) |
| Lawrence 2014 | Feb 2012 Jun 2012 | MR450, GE | 1.5 & 3 | T2, DWI | No | PI‐RADS v1 | Experienced / Yes | BiopSee, Pi Medical/MedCom (rigid) | 7/pt (range 0‐14) |
| Mortezavi 2018 | Nov 2014 Sep 2016 | Magnetom Skyra, Siemens | 3 | T2, DWI, DCE | Yes/No | PI‐RADS v1 | Experienced / Yes and No | BiopSee, Pi (Medical)/MedCom (non‐rigid) | 2‐4/lesion |
| Muthuveloe 2016 | Mar 2013 Dec 2014 | NR | NR | T2, DWI, DCE | NR | PI‐RADS v1 | Unclear / NR | NA | NA |
| Pepe 2013 | Jun 2011 Dec 2012 | Achieva, Philips | 3 | T2, DWI, DCE, spectroscopy | No | In‐house | Unclear / No | Cognitive | 3,5/pt (range 3‐4) |
| Thompson 2016 | Apr 2012 Mar 2014 | NR | 1.5 & 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / Yes | BioJet, Geoscan (rigid) | NR |
| Tsivian 2017 | 2011 2014 | Signa HDx, GE/Skyra, Siemens | 3 | T2, DWI, DCE | Yes/No | PI‐RADS v1a | Experienced / No | NA | NA |
| Agreement analyses studies | |||||||||
| Alberts 2017 | Oct 2013 Apr 2016 | Discovery MR750, GE | 3 | T2, DWI, DCE | No | PI‐RADS v2 | Experienced / Yes | Urostation, Koelis (elastic) | 2‐3/pt |
| Boesen 2017a | Sep 2012 Sep 2013 | Ingenia, Philips | 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / No | Real‐Time Virtual Sonography, Hitachi (rigid) | 1‐2/lesion |
| Boesen 2018 | Nov 2015 Jun 2017 | Philips Healthcare | 3 | T2, DWI | No | PI‐RADS v2a | Experienced / No | HI‐RVS (Hitachi; n=877), Uro‐Nav system (Invivo; n=143) | 1‐2/lesion |
| Castellucci 2017 | Jul 2011 Jul 2014 | Achieva, Philips | 1.5 | T2, DWI | NR | PI‐RADS v1 | Experienced / Yes | Cognitive | 2/lesion |
| Chang 2017 | Mar 2012 Dec2014 | Signa HDx, GE | 3 | T2, DWI, DCE | NR | PI‐RADS v1, v2 | Experienced / NR | Cognitive | ≥ 2/lesion |
| Chen 2015 | Jun 2008 Dec 2013 | Achieva, Philips | 3 | T2, DWI | No | In‐house | Experienced / NR | Cognitive | 1‐2/lesion |
| Cool 2016 | Sep 2011 Mar 2014 | NR, GE | 3 | T2, DWI, DCE | Yes/No | In‐house | Experienced / No | Artemis, Eigen (elastic) | 1.9/lesion |
| Costa 2013 | Aug 2003 Aug 2008 | Genesis Signa LX Excite, GE | 3 | T2, DCE | Yes | In‐house | Experienced / NR | Cognitive | NR |
| Delongchamps 2013 | Jan 2011 Mar 2012 | NR | 1.5 | T2, DWI, DCE | Yes/No | In‐house | Experienced / Yes | Urostation, Koelis (elastic)/Virtual Navigator, Esaote (rigid)/Cognitive | 4/pt (range 2‐10) |
| Filson 2016 | Sep 2009 Feb 2015 | TrioTim Somatom, Siemens | 3 | T2, DWI, DCE | No | In‐house | Experienced / No | Artemis, Eigen (elastic) | 1 per 3 mm. lesion diameter |
| Garcia Bennett 2017 | Oct 2014 Apr 2016 | Signa, GE | 3 | T2, DWI | No | PI‐RADS v1 | Experienced / Yes | Cognitive | NR |
| Grönberg 2018 | May 2016 May 2017 | Magnetom Avanto, Siemens/Magnetom Aera, Siemens | 1.5 | T2, DWI | No | PI‐RADS v2 | Experienced / Yes | Urostation, Koelis/Artemis, Eigen/BioJet, D&K Technologies | NR |
| Jambor 2015 | Apr 2011 Mar 2013 | Magnetom Verio, Siemens | 3 | T2, DWI, DCE, spectroscopy | No | In‐house | Unclear / NR | Cognitive | NR |
| Jambor 2017 | Mar 2013 Feb 2015 | Magnetom Verio, Siemens | 3 | T2, DWI | NR | In‐house | Experienced/ No | Cognitive | 2/index lesion |
| Kim 2017 | Jan 2012 Dec 2015 | Magnetom Trio/Skyra, Siemens | 3 | T2, DWI, DCE | No | In‐house, PI‐RADS v1, v2 | Experienced / No | UroNav, Invivo (rigid) | 6.7/pt |
| Lee 2016 | Jan 2014 Dec 2014 | Intera Achieva, Philips | 3 | T2, DWI | No | In‐house | Experienced / NR | Cognitive | 2.4/pt |
| Lee 2017 | 2016 | Intera Achieva, Philips | 3 | T2, DWI, (DCE 55 pts) T2, DWI (68 pts) | No | PI‐RADS v2a | Experienced / NR | Cognitive | NR |
| Okcelik 2016 | Feb 2013 Mar 2014 | Avanto, Siemens | 1.5 | T2, DWI, DCE, spectroscopy | NR | In‐house | Unclear / NR | Cognitive | NR |
| Panebianco 2015 | Oct 2011 Mar 2014 | Discovery MR750, GE/Magnetom Verio, Siemens | 3 | T2, DWI, DCE | Yes/No | PI‐RADS v1 | Experienced / Yes | Cognitive | 2/pt |
| Peltier 2015 | Mar 2012 Sep 2013 | Magnetom Verio, Siemens | 3 | T2, DWI, DCE | Yes/No | PI‐RADS v1a | Experienced / No | Urostation, Koelis (elastic) | 2,4/lesion (range 1‐4) |
| Pokorny 2014 | Jul 2012 Jan 2013 | Magnetom Skyra, Siemens | 3 | T2, DWI, DCE | No | PI‐RADS v1 | Experienced / Yes | In‐bore | 2/pt (range 2‐3) |
| Rouvière 2019a | Jul 2015 Aug2016 | MR 750, GE/MR 450, GE/Ingenia, Philips/Avanto, Siemens/Intera, Philips/Aera, Siemens/Achieva, Philips/Skyra, Siemens/Priesma, Siemens | 1.5 & 3 | T2, DWI, DCE | Yes/No | PI‐RADS v1/v2a | Experienced / No | Urostation, Koelis/Smart Fusion, Toshiba/Percunav, Philips | 3/lesion |
| Say 2016 | Dec 2012 Jun 2015 | NR | NR | T2, DWI, DCE | NR | In‐house, PI‐RADS v1 | Unclear / NR | Artemis, Eigen (elastic) | NR |
| Tonttilla 2016 | Apr 2011 Dec 2014 | Magnetom Skyra, Siemens | 3 | T2, DWI, DCE | No | In‐house | No experience / Unclear | Cognitive | 2/pt (range 2‐3) |
| Van der Leest 2018 | Feb 2015 Feb 2017 | Magnetom Skyra, Siemens | 3 | T2, DWI, DCE | NR | PI‐RADS v2 | Experienced / Yes | In‐bore, Invivo | 2‐4/lesion |
|
abased on the PI‐RADS v1/v2 guidelines but either before official publication or practically identical. DCE: dynamic contrast‐enhanced imaging; DWI: diffusion‐weighted imaging; MRI: magnetic resonance imaging; NA: not applicable; NR: not reported; PI‐RADS v1, v2: Prostate Imaging Reporting Data System version 1 or 2; pt(s): participant(s); SBx: systematic biopsy; T2: T2‐weighted imaging | |||||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.